logo
Share SHARE
FONT-SIZE Plus   Neg

GlaxoSmithKline Q1 Net Profit Down, Core EPS Up - Quick Facts

GlaxoSmithKline plc (GSK.L,GSK: Quote) reported a drop in first-quarter profit attributable to shareholders to 1.325 billion pounds from 1.525 billion pounds last year, with earnings per share falling to 26.3 pence from 29.6 pence a year ago.

However, core earnings per share for the recent quarter were 27.3 pence, higher than the prior-year quarter's 25.9 pence, up 7% in CER terms and 5% in sterling terms reflecting the strengthening of Sterling against the Euro and higher exchange losses on settled inter-company transactions, partly offset by the weakness of Sterling against the US Dollar and Japanese Yen.

Group turnover for the quarter went up 2% to 6.64 billion pounds from 6.585 billion pounds in the comparable period. In addition, the board has declared a first interim dividend of 17 pence per share. The company's 2012 outlook for sales growth and gradual expansion of core margin remained unchanged.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
US Steel Corp. (X) Tuesday said it will "adjust operations" and temporarily idle a part of its Minntac plant in Mt. Iron, Minnesota, effective June 1. According to reports, the move would see about 700 employees laid off. The company said the decision was due to its current inventory levels and ongoing... Hewlett-Packard Co. (HPQ) has filed a lawsuit against Michael Lynch, the co-founder of Autonomy Corp., and its former Financial Chief Sushovan Hussain for a whopping $5.1 billion alleging that the executives misrepresented the financial situation of Autonomy. An HP's spokeswoman confirmed that the... Nine acres of green grass with 400 trees and a half-mile-long walk way. We are not talking about any park, but the expansive rooftop of Facebook's new office. The 430,000 square feet office is a single room and it might be the largest open floor plan in the world.
comments powered by Disqus
RELATED NEWS
Trade GSK now with 
Follow RTT